PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
These funds will be used to conduct basic HIV program evaluations of ART outcomes. Care and treatment outcomes for HIV patients receiving HIV/AIDS care and treatment services will be assessed. Demographic, clinical, and immunologic characteristics of the patients' population currently receiving ART will be described, and analyses of treatment outcomes over time on ART will be carried out. Findings from this study will provide policy-makers and implementing partners with information that will facilitate future ART program development. Quality provision of ART services is a priority of both PEPFAR and URT policies and guidelines. The findings of such evaluations have nation-wide relevance and are likely to impact on future cost-efficiencies and effective approaches to continue transitioning these services to local partners and government. These evaluations may also consider program integration, a key cornerstone of GHI policy.
The partner and sites to conduct these activities are still to be determined.
PEPFAR/T care and treatment program, at the patient level, aims at driving viral loads to undetectable levels, increasing CD4+ T cell counts, reducing morbidity, and prolonging survival among clients receiving ARVs. By September 2012, a total of 364,000 patients were reported to be receiving ARVs across 976 PEPFAR supported facilities. Since the beginning of the program in 2004, Tanzania has been using former WHO recommendations in the management of HIV patients with CD4 <200 cells/mm3 and WHO clinical stage III and IV as criteria for treatment initiation. Early initiation of treatment, treatment simplification and adoption of the 2010 WHO treatment guidelines are some of the ongoing changes in the country. In order to understand the long-term and short-term treatment outcomes that are associated with these changes, PEPFAR/T will conduct an ART outcome study to understand the relationship between changes in treatment practices and patient outcomes across the selected PEPFAR-supported facilities throughout Tanzania.
